Press Releases

2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Dec 2013 | Download as pdf

Soluble Therapeutics Inc. has a second cash infusion that will help the company continue its work in protein-based pharmaceuticals as well as more

Dec 2013 | Download as pdf

StemBioSys, a San Antonio-based bioscience startup, is looking to raise $8 million in new Series A investor funding. The company has already secured more

29 Nov 2013 | Download as pdf

Medical-device firm Xenex attracts big Investment. When Rackspace Hosting co-founder Morris Miller more

25 Nov 2013 | Download as pdf

Xenex CEO expects 2013 revenues to be north of $20 Million. Xenex Disinfection Services’ Morris Miller expects more

21 Nov 2013 | Download as pdf

Xenex Secures $11.3 Million in Funding; Superbug Zapping Robot Enhances Patient Safety by Eliminating Pathogens that Cause Hospital Infections more

14 Nov 2013 | Download as pdf

DNAtrix Announces Treatment of First Patient in Study with Recurrent Glioblastoma Using DNX-2401 and Temozolomide more

Sept 2013 | Download as pdf

Medical Innovation iTClamp Hemorrhage Control System Used for First Time in United States more

Aug 2013 | Download as pdf

BiO2 Medical Executes Full Commercialization in the United Kingdom Partnering with United Drug Medical (UDM) as an Exclusive Distributor for the Angel® Catheter.

SAN ANTONIO, Aug. 19, 2013 /PRNewswire/ -- BiO2 Medical, Inc., a Texas based medical device manufacturer with corporate offices in San Antonio, Texas, and R&D and manufacturing operations in Golden, Colorado, has signed a distribution agreement with Pyramed, a division of United Drug Medical (UDM). This milestone accomplishment grants Pyramed exclusive rights to distribute the Angel® Catheter throughout the UK and Ireland.

Pyramed is a dynamic, leading healthcare services company, which provides medical products and services in the UK and Ireland. Jane Williamson, National Sales Manager, commented, "We are delighted to partner with BiO2 Medical with the launch of the Angel® Catheter in the UK. Our ambition is to provide innovative products and solutions to our customers and we are very excited to be the first distributor for the new Angel® Catheter."

Jane Williamson continued to say, "This product introduction increases our portfolio of interventional products and we value the opportunity to be a leader in the management of pulmonary embolism with this new and pioneering device from BiO2 Medical."

Patrick Howe, BiO2 Medical's VP of Sales & Marketing stated the following, "Partnering with UDM represents a significant milestone in the commercialization of the Angel® Catheter. UDM's expertise in providing innovative therapies to critical care and interventional physicians makes them the perfect partner to distribute the Angel® Catheter."

Introducing first in class technologies, into health care systems in new geographies, requires knowledge of the regional reimbursement and market access specifics. Therefore, BiO2 Medical has been working with UK NHS market access specialist, Michael Branagan-Harris from Device Access UK to gain access into the NHS system for the Angel® Catheter.  Michael Branagan-Harris is an expert in medical device reimbursement; specializing in assisting US based companies introduce medical devices into the UK market.

BiO2 Medical has also created a UK subsidiary, BiO2 Medical Limited, to provide support as it expands its commercialization efforts throughout Europe, the Middle East, and Asia (EMEA).  By the end of Q4 2013, BiO2 Medical plans to expand its commercialization strategy into several countries throughout Europe and the Middle East.

For more information on Pyramed and UDM please visit

For more information on Device Access please visit

For more information on BiO2 Medical and the Angel® Catheter, please visit BiO2 Medical's recently updated website at

SOURCE BiO2 Medical, Inc. back

July 2013 | Download as pdf

DNAtrix, Inc. to Present Clinical Study Results for DNX-2401 (Delta 24-RGD), A Conditionally Replication-Competent Adenovirus more

July 2013 | Download as pdf

ArthroCare Announces Acquisition of ENTrigue Surgical, Inc more

May 2013 | Download as pdf

Vidacare projects big revenue spike for 2013 more

May 2013 | Download as pdf

BiO2 Medical's IDE Application for the Angel(TM) Catheter Receives FDA Approval more

May 2013 | Download as pdf

Medical Device Firm iTraumaCareTM Receives FDA 510(k) Clearance for iTClampTM Hemorrhage Control System more

May 2013 | Download as pdf

BiO2 Medical's IDE Application for the Angel(TM) Catheter Receives FDA Approval more

March 2013 | Download as pdf

Woman, 80, gets new blood clot prevention device more

Feb 2013 | Download as pdf

BioDtech, Inc. Issued New United States Patent more

Jan 2013 | Download as pdf

Successful Completion of Santalis Pharmaceuticals Initial Clinical Trials more